Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.0088
-0.0002
(-2.22%)
As of 10:36:49 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-27,520
-27,520
-50,668
-69,443
-49,798
Investing Cash Flow
175
175
288
-389
-485
Financing Cash Flow
13,511
13,511
-705
41,727
150,179
End Cash Position
12,685
12,685
26,520
77,605
105,710
Capital Expenditure
--
--
--
-414
-318
Issuance of Capital Stock
20,206
20,206
--
53,545
150,690
Free Cash Flow
-27,520
-27,520
-50,668
-69,857
-50,116
12/31/2021 - 11/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2HA.MU Spero Therapeutics Inc
0.5190
-9.74%
2GH.BE Merus NV
33.40
-4.57%
HQ1.MU Oruka Therapeutics Inc. R
7.30
-11.52%
5KW.F SkinBioTherapeutics plc
0.2620
0.00%
HPHA.F Heidelberg Pharma AG
2.8200
+6.42%
22Z.SG Zealand Pharma A/S
52.42
-10.09%
05Y.F Vivoryon Therapeutics N.V.
1.5980
-8.48%
FLUI.ST Fluicell AB (publ)
9.99
-14.32%
600161.SS TIANTAN BIO
22.02
+6.43%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.2950
-2.96%